Marc A. Pfeffer

TL;DR: A graded independent relation between higher levels of serum phosphate and the risk of death and cardiovascular events in people with prior myocardial infarction is found, most of whom had serum phosphate levels within the normal range.

TL;DR: In this article, the authors discuss potential novel therapies for these disorders, including: sildenafil, an unexpected option for anti-transition therapy; surgery for increased sphericity caused by chronic volume overload of mitral regurgitation; an antifibrotic peptide to inhibit the fibrogenic effects of transforming growth factor β; mechanical intervention in advanced heart failure; and stem-cell therapy.

TL;DR: In this experimental preparation of myocardial infarction and left ventricular dysfunction, survival was inversely related to size ofinfarction.

TL;DR: Hypertension can cause or is related to various cardiac manifestations, among them left ventricular hypertrophy, congestive heart failure, cardiac dysrhythmias, and ischemic heart disease.

TL;DR: Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.